Jane A. Thanassi

1.6k total citations
41 papers, 1.2k citations indexed

About

Jane A. Thanassi is a scholar working on Molecular Biology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Jane A. Thanassi has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Infectious Diseases and 10 papers in Molecular Medicine. Recurrent topics in Jane A. Thanassi's work include Cancer therapeutics and mechanisms (14 papers), Antibiotic Resistance in Bacteria (10 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). Jane A. Thanassi is often cited by papers focused on Cancer therapeutics and mechanisms (14 papers), Antibiotic Resistance in Bacteria (10 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). Jane A. Thanassi collaborates with scholars based in United States, United Kingdom and Switzerland. Jane A. Thanassi's co-authors include Michael J. Pucci, Gordon L. Archer, Debra M. Niemeyer, Michael J. Pucci, Steven D. Podos, Milind Deshpande, Barton J. Bradbury, Thomas J. Dougherty, Michael J. Pucci and Jason A. Wiles and has published in prestigious journals such as Nucleic Acids Research, Blood and Journal of Bacteriology.

In The Last Decade

Jane A. Thanassi

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane A. Thanassi United States	21	658	409	245	225	192	41	1.2k
Fuminori Kato Japan	19	536 0.8×	273 0.7×	160 0.7×	169 0.8×	228 1.2×	43	1.2k
Anatoly Severin United States	16	516 0.8×	323 0.8×	208 0.8×	143 0.6×	137 0.7×	24	981
Nagraj Mani United States	18	534 0.8×	588 1.4×	112 0.5×	174 0.8×	151 0.8×	36	1.3k
M.T. Hilgers United States	15	686 1.0×	428 1.0×	136 0.6×	147 0.7×	162 0.8×	17	1.1k
Ed T. Buurman United States	23	1.1k 1.6×	532 1.3×	247 1.0×	279 1.2×	146 0.8×	46	1.8k
Sergio Lociuro Switzerland	18	547 0.8×	225 0.6×	282 1.2×	62 0.3×	356 1.9×	37	1.3k
J. Harms Germany	11	1.5k 2.3×	263 0.6×	221 0.9×	453 2.0×	210 1.1×	13	2.0k
Frank Schlünzen Germany	14	1.5k 2.3×	267 0.7×	222 0.9×	459 2.0×	213 1.1×	16	2.1k
Magdalena Zalacaín United States	23	905 1.4×	181 0.4×	122 0.5×	193 0.9×	304 1.6×	40	1.4k
Liqun Xiong United States	19	1.5k 2.3×	716 1.8×	174 0.7×	442 2.0×	416 2.2×	20	2.2k

Countries citing papers authored by Jane A. Thanassi

Since Specialization

Citations

This map shows the geographic impact of Jane A. Thanassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane A. Thanassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane A. Thanassi more than expected).

Fields of papers citing papers by Jane A. Thanassi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane A. Thanassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane A. Thanassi. The network helps show where Jane A. Thanassi may publish in the future.

Co-authorship network of co-authors of Jane A. Thanassi

This figure shows the co-authorship network connecting the top 25 collaborators of Jane A. Thanassi. A scholar is included among the top collaborators of Jane A. Thanassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane A. Thanassi. Jane A. Thanassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wiles, Jason A., et al.. (2025). First-in-Class Clinically Investigated Oral Factor D Inhibitors for the Treatment of Complement-Mediated Diseases. Pharmaceutical Research. 42(7). 1119–1131.

Podos, Steven D., Howard Trachtman, Gerald B. Appel, et al.. (2022). Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan. American Journal of Nephrology. 53(10). 675–686. 11 indexed citations

Yuan, Xuan, Eleni Gavriilaki, Jane A. Thanassi, et al.. (2016). Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Haematologica. 102(3). 466–475. 82 indexed citations

Thanassi, Jane A., Guangwei Yang, Manuel Galvan, et al.. (2016). Comparison of complement functional assays: Differential sensitivities of hemolysis and Wieslab assays to levels of complement proteins C5, factor B, and factor D. Immunobiology. 221(10). 1169–1169. 1 indexed citations

Yuan, Xuan, Guangwei Yang, Jane A. Thanassi, et al.. (2016). Evaluation of Bacteria-Mediated Potential "Bystander" Hemolysis of PNH RED CELLS In Vitro: NO Evidence of Significant Complement Classical or Lectin Pathway-Mediated Hemolysis Induced by Microorganisms. Blood. 128(22). 2431–2431. 2 indexed citations

Ji, Cheng, Garrett C. Moraski, Jane A. Thanassi, et al.. (2012). Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels−Alder reaction. Bioorganic & Medicinal Chemistry. 20(11). 3422–3428. 6 indexed citations

Moraski, Garrett C., Jane A. Thanassi, Steven D. Podos, Michael J. Pucci, & Marvin J. Miller. (2011). One-step syntheses of nitrofuranyl benzimidazoles that are active against multidrug-resistant bacteria. The Journal of Antibiotics. 64(10). 667–671. 11 indexed citations

Aboul‐Fadl, Tarek, Hatem A. Abdel‐Aziz, Mohammed K. Abdel‐Hamid, et al.. (2011). Schiff Bases of Indoline-2,3-dione: Potential Novel Inhibitors of Mycobacterium Tuberculosis (Mtb) DNA Gyrase. Molecules. 16(9). 7864–7879. 42 indexed citations

Kim, Ha-Young, Jason A. Wiles, Qiuping Wang, et al.. (2011). Exploration of the Activity of 7-Pyrrolidino-8-methoxyisothiazoloquinolones against Methicillin-Resistant Staphylococcus aureus (MRSA). Journal of Medicinal Chemistry. 54(9). 3268–3282. 29 indexed citations

10.

Agarwal, Atul, Shirley Louise‐May, Jane A. Thanassi, et al.. (2007). Small molecule inhibitors of E. coli primase, a novel bacterial target. Bioorganic & Medicinal Chemistry Letters. 17(10). 2807–2810. 38 indexed citations

11.

Wang, Qiuping, Akihiro Hashimoto, Godwin C. G. Pais, et al.. (2006). Isothiazoloquinolones with Enhanced Antistaphylococcal Activities against Multidrug-Resistant Strains: Effects of Structural Modifications at the 6-, 7-, and 8-Positions. Journal of Medicinal Chemistry. 50(2). 199–210. 40 indexed citations

12.

Wiles, Jason A., Yongsheng Song, Qiuping Wang, et al.. (2005). Biological evaluation of isothiazoloquinolones containing aromatic heterocycles at the 7-position: In vitro activity of a series of potent antibacterial agents that are effective against methicillin-resistant Staphylococcus aureus. Bioorganic & Medicinal Chemistry Letters. 16(5). 1277–1281. 22 indexed citations

13.

Constantine, Keith L., Stanley R. Krystek, Matthew D. Healy, et al.. (2005). Structural and functional characterization of CFE88: Evidence that a conserved and essential bacterial protein is a methyltransferase. Protein Science. 14(6). 1472–1484. 4 indexed citations

14.

Wiles, Jason A., Qiuping Wang, Akihiro Hashimoto, et al.. (2005). Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: Synthesis and in vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells. Bioorganic & Medicinal Chemistry Letters. 16(5). 1272–1276. 41 indexed citations

15.

Thanassi, Jane A.. (2002). Identification of 113 conserved essential genes using a high-throughput gene disruption system in Streptococcus pneumoniae. Nucleic Acids Research. 30(14). 3152–3162. 177 indexed citations

16.

Discotto, Linda, Jane A. Thanassi, Hesna Yigit, et al.. (2001). American Society of Microbiology 101st General Meeting. Expert Opinion on Investigational Drugs. 10(8). 1575–1599. 1 indexed citations

17.

Archer, Gordon L., Debra M. Niemeyer, Jane A. Thanassi, & Michael J. Pucci. (1994). Dissemination among staphylococci of DNA sequences associated with methicillin resistance. Antimicrobial Agents and Chemotherapy. 38(3). 447–454. 116 indexed citations

18.

Dougherty, Thomas J., Jane A. Thanassi, & Michael J. Pucci. (1993). The Escherichia coli mutant requiring D-glutamic acid is the result of mutations in two distinct genetic loci. Journal of Bacteriology. 175(1). 111–116. 33 indexed citations

19.

Handwerger, S, Linda Discotto, Jane A. Thanassi, & Michael J. Pucci. (1992). Insertional inactivation of a gene which controls expression of vancomycin resistance on plasmid pHKK100. FEMS Microbiology Letters. 92(1). 11–14. 14 indexed citations

20.

Davis, Jonathan R., Joseph F. Cortese, D A Herrington, et al.. (1992). Plasmodium falciparum: In vitro characterization and human infectivity of a cloned line. Experimental Parasitology. 74(2). 159–168. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact